title: Anaphylatoxins in organ transplantation.
abstract: C3a and C5a (also called anaphylatoxins) are inflammatory peptides generated during complement activation. They do not only play important roles in innate immunity through the initiation and regulation of inflammatory responses, but also significantly influence adaptive immune responses. Organ transplantation triggers an initial inflammatory response and subsequent to the specific immune response (also called the alloimmune response), both of which contribute to graft rejection. Emerging evidence suggests that anaphylatoxins, particularly C5a, are significantly involved in both inflammatory and alloimmune responses following organ transplantation, thus influencing graft outcome. This review will provide the information on our current understanding of the roles for anaphylatoxins in ischemia-reperfusion injury, graft rejection, and transplant tolerance, and the therapeutic potential of targeting anaphylatoxin receptors in organ transplantation.
authors.affiliation: Core Research Laboratory, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, China.
authors.forename: Ke
authors.initials: K
authors.lastname: Li
authors.forename: Wuding
authors.initials: W
authors.lastname: Zhou
mesh_terms: D000706:Anaphylatoxins / Q000276:immunology*; D000818:Animals; D003182:Complement C5 / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D058990:Molecular Targeted Therapy; D016377:Organ Transplantation; D014181:Transplantation Immunology; D023001:Transplantation Tolerance / Q000276:immunology
chemical_list: D000706:Anaphylatoxins; D003182:Complement C5
keywords: C3a; C5a; Graft rejection; Organ transplantation; Reperfusion injury; Transplant tolerance